Inactive Instrument

Innovotech Inc Share Price Toronto S.E.

Equities

IOT

CA45772U1049

Biotechnology & Medical Research

Financials

Sales 2022 1.13M 822K 68.77M Sales 2023 1.18M 864K 72.24M Capitalization 2.92M 2.13M 178M
Net income 2022 - 0 0 Net income 2023 - 0 0 EV / Sales 2022 4.21 x
Net cash position 2022 514K 375K 31.38M Net cash position 2023 229K 167K 13.97M EV / Sales 2023 2.27 x
P/E ratio 2022
-38.5 x
P/E ratio 2023
-18.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 57.13%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 19/19/19
Director of Finance/CFO - 30/13/30
Chairman - 22/02/22
Members of the board TitleAgeSince
Director/Board Member - 15/19/15
Chairman - 22/02/22
Director of Finance/CFO - 30/13/30
More insiders
Innovotech Inc. is a Canada-based biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.
More about the company